ES2172182T3 - Composiciones farmaceuticas que comprenden cefuroxima axetil. - Google Patents

Composiciones farmaceuticas que comprenden cefuroxima axetil.

Info

Publication number
ES2172182T3
ES2172182T3 ES98940001T ES98940001T ES2172182T3 ES 2172182 T3 ES2172182 T3 ES 2172182T3 ES 98940001 T ES98940001 T ES 98940001T ES 98940001 T ES98940001 T ES 98940001T ES 2172182 T3 ES2172182 T3 ES 2172182T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
axetil
cefuroxima
precipitate
making
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98940001T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4161029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2172182(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2172182T3 publication Critical patent/ES2172182T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

Un coprecipitado de cefuroxima axetil y un excipiente hidrosoluble. Procedimiento de fabricación de dicho coprecipitado y composiciones farmacéuticas para administración por vía oral que contienen dicho coprecipitado.
ES98940001T 1997-08-15 1998-08-07 Composiciones farmaceuticas que comprenden cefuroxima axetil. Expired - Lifetime ES2172182T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002209868A CA2209868C (en) 1997-08-15 1997-08-15 Pharmaceutical compositions comprising cefuroxime axetil

Publications (1)

Publication Number Publication Date
ES2172182T3 true ES2172182T3 (es) 2002-09-16

Family

ID=4161029

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98940001T Expired - Lifetime ES2172182T3 (es) 1997-08-15 1998-08-07 Composiciones farmaceuticas que comprenden cefuroxima axetil.

Country Status (7)

Country Link
EP (1) EP0996449B1 (es)
AT (1) ATE213416T1 (es)
AU (1) AU8847098A (es)
CA (1) CA2209868C (es)
DE (1) DE69803930T2 (es)
ES (1) ES2172182T3 (es)
WO (1) WO1999008683A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0937727B1 (de) * 1998-02-20 2002-01-30 Fako Ilaclari A.S. Verfahren zur Herstellung vom löslichen kristallinen Cefuroxim axetil
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
AT413647B (de) * 1998-11-26 2006-04-15 Sandoz Ag Verwendung eines copolymerisats aus 1-vinyl-2-pyrrolidon und vinylacetat zur herstellung von cefuroximaxetil-hältigen tabletten
CA2280925A1 (en) 1999-07-29 2001-01-29 Bernard Charles Sherman Stabilized cefuroxime axetil
CZ12993U1 (cs) * 2001-11-23 2003-02-10 Glaxo Group Limited Farmaceutický prostředek
WO2005002540A2 (en) * 2003-07-01 2005-01-13 Ranbaxy Laboratories Limited Dry powder pharmaceutical suspension compositions of cefuroxime axetil
JP2007517864A (ja) * 2004-01-09 2007-07-05 ハンミ ファーム． シーオー．， エルティーディー． セフロキシムアキセチル顆粒及びこの製造方法
CN100402035C (zh) * 2005-07-07 2008-07-16 石药集团中奇制药技术（石家庄）有限公司 一种微囊化头孢呋辛酯的药物组合物
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
CN101890023B (zh) * 2010-08-16 2013-03-27 海南日中天制药有限公司 头孢呋辛酯口服剂及其制备方法
CN115887468B (zh) * 2022-11-17 2025-02-07 华北制药河北华民药业有限责任公司 一种空心球形头孢呋辛酯制剂原粉及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8320521D0 (en) * 1983-07-29 1983-09-01 Glaxo Group Ltd Chemical process
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
CA1316110C (en) * 1987-02-27 1993-04-13 Eli Lilly And Company Sustained release matrix formulations
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
DE19631085A1 (de) * 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Maleinsäure-Copolymeren zur Verbesserung der Permeabilität der Schleimhaut
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT

Also Published As

Publication number Publication date
DE69803930T2 (de) 2002-10-17
ATE213416T1 (de) 2002-03-15
EP0996449A1 (en) 2000-05-03
EP0996449B1 (en) 2002-02-20
DE69803930D1 (de) 2002-03-28
CA2209868C (en) 2001-08-14
WO1999008683A1 (en) 1999-02-25
CA2209868A1 (en) 1999-02-15
AU8847098A (en) 1999-03-08

Similar Documents

Publication Publication Date Title
FI973749A7 (fi) Suun kautta annosteltava 2-metyylitienobentsodiatsepiinivalmiste
EE9900441A (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks
SE9704545D0 (sv) Novel compounds
SE9704544D0 (sv) Novel compounds
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
AU7052698A (en) Pharmaceutical composition for oral administration of a n-piperidino- 3-pyrazolecarboxamide derivative, its salts and their solvates
HUP9900391A2 (hu) Rapamicineket tartalmazó gyógyszerkészítmények
IT1240765B (it) Composizioni farmaceutiche a base di ciclosporine.
EE9600118A (et) Uus peroraalne farmatseutiline annusvorm
HUP9800688A2 (hu) Gamma-ciklodextrin és retinol, ill. retinolszármazékok komplexei, eljárás ezek előállítására és ezeket tartalmazó kozmetikai és gyógyszerkészítmények
LU91122I2 (fr) Efalizumab et ses dérivés pharmaceutiquement acceptables (raptiva).
FR2764889B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
NO991405L (no) Belagt partikkelformulering
FI980862A0 (fi) Kiraalisia metyylifenyylioksatsolidinoneja
FI951357L (fi) Farmaseuttiset koostumukset, jotka mahdollistavat trimetatsidiinin hidastetun vapautumisen oraalisen annostuksen jälkeen
NO972391D0 (no) 2-substituerte 1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og metoder for anvendelse derav
ES2160145T3 (es) Composicion farmaceutica para la administracion oral de flavonoides.
ES2172182T3 (es) Composiciones farmaceuticas que comprenden cefuroxima axetil.
FI954986L (fi) Uudet, suun kautta annettavat, syklosporiinia sisältävät farmaseuttiset valmisteet
CZ282732B6 (cs) Substituované 1,2,3,4-tetrahydrocyklopent/b/indoly, 1,2,3,3a,4,8a-hexahydrocyklopent/b/indoly a příbuzné sloučeniny, meziprodukty a způsob jejich přípravy a jejich použití jako léčiv
FI910088L (fi) Oral farmaceutisk komposition.
GB9907571D0 (en) Compounds
PT1131297E (pt) Certas caprolactamas substituidas composicoes farmaceuticas contendo-as e sua utilizacao no tratamento de tumores
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
FR2674755B1 (fr) Nouvelles compositions medicamenteuses immunostimulatrices.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 996449

Country of ref document: ES